2018/Dec/25

Announcement of Financial Results for 3Q, FY2018

2018/Nov/09

(Complete version) Quarterly financial summary ended September 30, 2018

2018/Oct/31

Announcement of Financial Results 2Q, FY2018

2018/Oct/31

Supplementary Data of Consolidated Financial Statements for the second quarter ended September 30, 2018

2018/Oct/31

Summary of Consolidated Financial Statements for the Second Quarter Ended September 30, 2018 (IFRS Basis)

2018/Sep/28

Notice Concerning the Company Split (Absorption-type Split）with a Consolidated Subsidiary

2018/Sep/25

2018/Oct/31 Announcement of Financial Results for 2Q, FY2018

2018/Aug/07

(Complete version) Quarterly financial summary ended June 30, 2018

2018/Aug/01

Results and Completion of Share Repurchase

2018/Jul/31

Announcement of Financial Results 1Q, FY2018

2018/Jul/31

Supplementary Data of Consolidated Financial Statements for the first quarter ended June 30, 2018

2018/Jul/31

Summary of Consolidated Financial Statements for the First Quarter Ended June 30, 2018 (IFRS Basis)

2018/Jul/10

Notice Concerning the Status of Share Repurchase

2018/Jun/25

Nitto’s Position and Policy Regarding Lowering of Trading Unit

2018/Jun/25

2018/Jul/31 Announcement of Financial Results for 1Q, FY2018

2018/Jun/22

Shareholders' Meeting has been updated

2018/Jun/22

Notice Concerning Disposition of Treasury Shares as Remuneration for Restricted Shares

2018/Jun/07

Notice Concerning the Status of Share Repurchase

2018/Jun/01

Shareholders' Meeting has been updated

2018/May/10

Notice Concerning the Status of Share Repurchase

2018/May/10

(Complete version) Financial summary ended March 31, 2018

2018/Apr/27

Announcement of Financial Results of FY2017

2018/Apr/27

Notice Concerning Introduction of Restricted Share and Performance-Linked Share-Based Remuneration Plan

2018/Apr/27

Supplementary Data of Consolidated Financial Statements for the year ended March 31, 2018

2018/Apr/27

Summary of Consolidated Financial Statements of Fiscal 2017 (12 Months Ended March 31, 2018 (IFRS Basis))

2018/Apr/04

Notice Concerning the Status of Share Repurchase

2018/Mar/30

Findings of the Nitto Board Effectiveness Evaluation

2018/Mar/26

2018/Apr/27 Announcement of Financial Results for Fiscal 2017

2018/Mar/09

Notice Concerning the Status of Share Repurchase

2018/Mar/05

La FDA admite a trámite la solicitud para la indicación del producto en fase de investigación clínica ND-L02-s0201 en la fibrosis pulmonar idiopática

2018/Feb/14

Nitto and Sumitomo Dainippon Pharma Announce Positive Topline Results from Phase 3 Study Evaluating Transdermal Patch Formulation of Atypical Antipsychotic LONASEN™

2018/Jan/31

Notice of Change in Consolidated Subsidiary with Transfer of Shares

2018/Jan/31

Resolution Regarding Share Repurchase

2018/Jan/31

Announcement of Financial Results 3Q, FY2017

2018/Jan/31

Notice of Change in Consolidated Subsidiary with Transfer of Shares

2018/Jan/31

Resolution Regarding Share Repurchase